Dynamically decreased miR-671-5p expression is associated with oncogenic transformation and radiochemoresistance in breast cancer.
Xiaohui TanZhongwu LiShuchang RenKatayoon RezaeiQing PanAndrew T GoldsteinCharles J MacriDengfeng CaoRachel F BremSidney W FuPublished in: Breast cancer research : BCR (2019)
miR-671-5p displays a dynamic decrease expression during the oncogenic transition of BC by suppressing FOXM1-mediated EMT and DNA repair. Therefore, miR-671-5p may serve as a novel biomarker for early BC detection as well as a therapeutic target for BC management.